radiomics-based test for lung nodule risk assessment — Conference presentation
Dec 3
Initial data for this new test will be presented at RSNA on December 3, 2026, and commercial availability is anticipated in 2028.Source filing
BDSX biotech catalysts & pipeline
BIODESIX INC · Data as of 2026-10-25